col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


215 Results       Page 1

 [1] 
Elsevier: Annals of Allergy Asthma & Immunology
  original article Date Title Authors   All Authors
1 [GO] 2024―Jan―21 Association between allergic conditions and COVID-19 susceptibility and outcomes Chao Chen, Xue Song, Dana J. Murdock, Andrea Marcus, Mohamed Hussein, Jessica J. Jalbert, Gregory P. Geba
2 [GO] 2024―Jan―18 The Impact of Coronavirus Disease 2019 (COVID-19) Vaccine Reactions on Secondary Vaccine Hesitancy Esther E. Freeman, Alexis G. Strahan, Liam R. Smith, Allen D. Judd, Upeka Samarakoon, Geoffrey Chen, et al. (+2)
3 [GO] 2023―Dec―03 Case series of patients with acute and chronic urticaria after COVID-19 vaccination Andrew Nickels, Supriya Varadarajulu, Pamela Harris, Alexandra Graden, Annely Richardson, Trisha Saha, et al. (+3)
4 [GO] 2023―Nov―09 AGE, SEX, OBESITY, AND CONTROLLER THERAPY MODERATE THE RELATIONSHIP BETWEEN PEDIATRIC ASTHMA EXACERBATIONS AND COVID-19 J. Barrows, S. Galant, T. Morphew
5 [GO] 2023―Nov―09 ASSESSING SEVERITY OF COVID-19 AND THE DEVELOPMENT OF MIS-C IN PEDIATRIC PATIENTS WITH ATOPIC DISEASE N. Rudsenske, J. Perkins
6 [GO] 2023―Nov―09 INCIDENCE AND PREDICTORS OF CUTANEOUS REACTIONS TO THE COVID-19 BOOSTER VACCINE R. Shah, A. King, E. Shenoy, A. Landman, D. Hashimoto, K. Blumenthal
7 [GO] 2023―Nov―09 PROTEIN LOSING ENTEROPATHY, HYPOALBUMINEMIA, HYPOGAMMAGLOBULINEMIA AND ANASARCA ASSOCIATED WITH RECURRENT COVID-19 INFECTION C. Gunderson, C. Chang, N. Hamburger
8 [GO] 2023―Nov―09 UNDEFINED AUTOINFLAMMATORY CONDITION FOLLOWING COVID-19 INFECTION O. Humpel, L. Nagireddi, R. Hostoffer
9 [GO] 2023―Nov―09 FROM SEVERE COVID-19 INFECTION TO GENETIC REVELATION: TOLL-LIKE RECEPTOR 7 DEFICIENCY IN TWO BROTHERS B. Schornack, M. Leondaridis, J. McMurray, N. Boggs, A. Snow
10 [GO] 2023―Nov―09 GRAFT-VERSUS-HOST-DISEASE - A RARE COVID-19 MRNA VACCINE SIDE EFFECT IN POST STEM CELL TRANSPLANT PATIENTS K. Sese
11 [GO] 2023―Nov―09 THE EFFECT OF COVID-19 ON PEDIATRIC ASTHMA ICU ADMISSIONS AT A SINGLE CENTER. P. Le
12 [GO] 2023―Nov―09 ALLERGY IMMUNOLOGY FELLOWSHIP EDUCATION DURING COVID-19 PANDEMIC A. Yeich, M. Matheny, N. Maglakelidze, L. Mazur, T. Craig
13 [GO] 2023―Nov―09 SARS-COV2 SPECIFIC ANTIBODY RESPONSES TO COVID-19 VACCINATION IN COMMON VARIABLE IMMUNODEFICIENCY K. Zhang, S. Agrawal, S. Gupta
14 [GO] 2023―Nov―09 AUTOIMMUNE RESPONSE TO THE COVID-19 VACCINE ELICITING VITILIGO A. Mittman
15 [GO] 2023―Nov―09 DOUBLE BLIND RANDOMIZED CONTROLLED TRIAL OF SALINE SOLUTION GARGLING AND NASAL RINSING IN SARS-COV-2 INFECTION S. Espinoza, L. Trauffler, A. Shamshirsaz, A. Shamshirsaz, A. Espinoza, J. Espinoza, A. O'Brien
16 [GO] 2023―Nov―09 EFFECT OF THE SARS-COV-2 PANDEMIC ON PEDIATRIC ASTHMA HEALTH-CARE UTILIZATION IN AN URBAN TERTIARY-CARE HOSPITAL H. Zomer Bolanos, M. Reznik, E. Rothschild, L. Conrad, M. Cabana
17 [GO] 2023―Nov―09 CD14 (C-159)T GENE POLYMORPHISM IN SARS-COV-2 PATIENTS IN CRIMEA V. Beloglazov, I. Yatskov, L. Dudchenko, E. Ageeva, L. DuBuske
18 [GO] 2023―Nov―09 THE NOISE ABOUT SARS-COV-2 VACCINATION: A RETROSPECTIVE COHORT STUDY EVALUATING TINNITUS AND VACCINATION J. Pollock, D. Hoffman, A. Tolisano, L. Housel, R. Lee
19 [GO] 2023―Nov―09 FREQUENCY OF T-330G IL-2 GENE SNP IN SARS-COVID-19 PATIENTS V. Beloglazov, I. Yatskov, E. Ageeva, L. DuBuske
20 [GO] 2023―Aug―23 Population-Level Trends in Asthma and COPD Emergency Department Visits and Hospitalizations Before and During the COVID-19 Pandemic in the US Adam Gaffney, David U. Himmelstein, Steffie Woolhandler
21 [GO] 2023―Aug―07 Asthma in elderly and COVID-19: results of 90-day post-hospital follow-up Sergey N. Avdeev, Viliya V. Gaynitdinova, Anna A. Pozdnakova, Svetlana Yu Chikina, Karina A. Kosobokova
22 [GO] 2023―Aug―01 Did the coronavirus disease 2019 pandemic change asthma prevalence? Rebecca Koenigsberg, Mitchell H. Grayson
23 [GO] 2023―Jul―05 Intranasal steroid use and COVID-19 mortality among asthma and COPD patients: A retrospective cohort study Dr Virginia Hernandez Santiago, Dr Adeniyi Francis Fagbamigbe, Prof Frank Sullivan, Dr Utkarsh Agrawal, Dr Daniel Morales, Prof Colin McCowan, Prof Brian Lipworth
24 [GO] 2023―Jun―15 Controller therapy attenuates asthma exacerbations associated with prior SARS-CoV-2 infection in children Iris Kim, Tricia Morphew, Christine Chou, Louis Ehwerhemuepha, Stanley Galant
25 [GO] 2023―May―03 Changes in the national prevalence of asthma and COVID-19 fatality: A population-based cross-sectional study Martín Bedolla-Barajas, Jaime Morales-Romero, Martín Robles-Figueroa, Tonatiuh Delgado-Figueroa
26 [GO] 2023―Apr―19 Asthma medication adherence during the COVID-19 pandemic in children at high risk of exacerbation Colleen M Shannon, Carina Flaherty, William O Quarshie, Rui Xiao, Chén C Kenyon
27 [GO] 2023―Apr―07 COVID-19 vaccine skin testing and graded challenges in vaccine hesitant patients Ari Heffes-Doon, Nathanael Horne, Chinyere Okpara, Meredith Akerman, Luz Fonacier
28 [GO] 2023―Mar―15 The Role of IL-13 and the Type 2 Immune Pathway in COVID-19: A Review Jennifer Sasson, G. Brett Moreau, William A. Petri
29 [GO] 2023―Feb―02 Antibody and T-cell responses to COVID-19 Vaccination in Common Variable Immunodeficiency and Specific Antibody Deficiency Jamie A. Rosenthal, Michelle Premazzi Papa, Marta Sanz, Samuel Nicholes, Carissa Stower, Alberto Bosque, et al. (+5)
30 [GO] 2022―Dec―10 Impact of Vaccination against SARS-CoV-2 on the Atopic Dermatitis Serum Proteome Madeline Kim, Benjamin Ungar, Yeriel Estrada, Ana B. Pavel, Emma Guttman-Yassky
31 [GO] 2022―Dec―01 Is there value in coronavirus disease 2019 vaccine and vaccine excipient skin testing or split dosing? Matthew Greenhawt
32 [GO] 2022―Dec―01 Split-dosing of coronavirus disease 2019 vaccines Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
33 [GO] 2022―Nov―10 DETERIORATION OF RESPIRATORY STATUS IN A CVID PATIENT WITH GLILD AND COVID-19 N. Kimura, A. Jongco
34 [GO] 2022―Nov―10 A CASE SERIES: CHRONIC INDUCIBLE URTICARIA FOLLOWING COVID-19 INFECTION AND MRNA VACCINE T. Hellu, S. Weiss, K. Adams
35 [GO] 2022―Nov―10 A CASE OF PULMONARY EMBOLISM POST COVID-19 INFECTION IN A PATIENT WITH STAT3 MUTATION H. Blunk, K. Birch, M. Callahan, R. Hostoffer
36 [GO] 2022―Nov―10 THE IMPORTANCE OF B CELLS IN OVERCOMING COVID-19 INFECTION IN COMMON VARIABLE IMMUNODEFICIENCY PATIENTS. J. Brozyna, H. Li, A. Hassoun, F. Ibrahim
37 [GO] 2022―Nov―10 INCIDENCE OF COVID-19 INFECTIONS IN ADULTS WITH PRIMARY IMMUNODEFICIENCY AFTER RECEIVING TIXAGEVIMAB AND CILGAVIMAB S. Johnson, J. Fernandez
38 [GO] 2022―Nov―10 OUTCOMES AND IMPACT OF COVID-19 ON INFECTION DIAGNOSIS RATES AMONG PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES F. Riaz, K. Umashankar, E. Marchlewicz, K. Zhang, M. Sanchirico
39 [GO] 2022―Nov―10 LIKELIHOOD OF DIAGNOSIS OF EOSINOPHILIC ESOPHAGITIS VIA ENDOSCOPY IN DYSPHAGIA DURING THE COVID-19 PANDEMIC J. Brennan, K. Yamada, T. Al-Shaikhly, G. Ghaffari
40 [GO] 2022―Nov―10 THE IMPACT OF COVID-19 PANDEMIC ISOLATION MEASURES ON PEDIATRIC ASTHMA ADMISSIONS S. Raja, V. Nguyen, R. Heinle, J. Hossain
41 [GO] 2022―Nov―10 BIOMARKERS OF CYTOKINE STORM AND INFLAMMATION IN SEPSIS, POST-COVID-19 PATIENTS AND COVID-19 VACCINATED INDIVIDUALS L. Titov, M. Trusevich, T. Amvrosieva, I. Belskaya, Y. Gorbich, L. DuBuske
42 [GO] 2022―Nov―10 POLYMYALGIA RHEUMATICA AFTER MRNA COVID-19 VACCINATION N. Trotto, S. Hauk, S. Fowler, B. McGoey, J. Ravell
43 [GO] 2022―Nov―10 SECONDARY URTICARIAL VASCULITIS AND CHRONIC SPONTANEOUS URTICARIA ASSOCIATED WITH COVID-19 VACCINATION T. Chang, F. Tachibana, V. Wang, J. Yusin
44 [GO] 2022―Nov―10 PRE-VACCINE COUNSELING TO ASSIST WITH RISK ASSESSMENT PRIOR TO COVID-19 VACCINATION J. Rosenblum, C. Yie, M. Akerman, E. Banta
45 [GO] 2022―Nov―10 PERSISTENT ANGIOEDEMA AFTER COVID-19 VACCINATION: IS BRADYKININ TO BLAME? G. Edland, S. Awan, A. James, A. Keswani
46 [GO] 2022―Nov―10 COVID-19 VACCINE ADMINISTRATION IN PATIENTS WITH FIRST-DOSE ADVERSE REACTIONS OR HISTORY OF SEVERE ALLERGIC REACTION K. Vanijcharoenkarn, F. Lee, M. Kalangara
47 [GO] 2022―Nov―10 COVID-19 VACCINE REACTIONS AND SUSPECTED POLYETHYLENE GLYCOL ALLERGY: A PEDIATRIC CASE SERIES M. Laditan, A. Martone, D. Doshi
48 [GO] 2022―Nov―10 REDUCED COVID-19 VACCINE RESPONSE IN PATIENT TREATED WITH DUPILUMAB FOR IGG4 RELATED DISEASE. A. Abadeh, J. Lee
49 [GO] 2022―Nov―10 MRNA COVID-19 VACCINE-ASSOCIATED BULLOUS FIXED DRUG ERUPTION S. Imam, T. Carpenter, A. Wolff, R. Khianey, E. Capitle
50 [GO] 2022―Nov―10 RISK OF ANAPHYLAXIS TO THE COMPONENTS OF THE COVID-19 VACCINE: A STUDY IN MEXICAN POPULATION R. Lopez Henriquez, J. Uc Rosado, S. Gonzalez-Diaz, R. Villarreal Gonzalez, C. De Lira-Quezada, A. Macias-Weinmann, et al. (+2)
51 [GO] 2022―Nov―10 REVISITING HYPERSENSITIVITY REACTIONS TO THE MRNA COVID-19 VACCINE: TOLERANCE AFTER PREVIOUS HISTORY OF ANAPHYLAXIS I. AlOtaibi, F. ALMuhizi, S. Ton-Leclerc, M. Fein, M. Ben-Shoshan, G. Isabwe, A. Copaescu
52 [GO] 2022―Nov―10 SPLIT-DOSING OF COVID-19 VACCINES IS SAFE AND PROVIDES NON-INFERIOR ANTIBODY RESPONSIVENESS TO CONVENTIONAL VACCINE DOSING A. Musa, M. Wood, S. May, A. Rorie, J. Van De Graaff, R. Walenz, et al. (+2)
53 [GO] 2022―Nov―10 IMMUNIZATION STRESS-RELATED RESPONSES DURING SKIN TESTING AND CHALLENGE TO COVID-19 VACCINES: A CASE SERIES H. Jin, L. Fonacier
54 [GO] 2022―Nov―10 TOLERABILITY OF GRADED CORONAVIRUS DISEASE 2019 MRNA VACCINE DOSING B. Hamel, M. Pitlick, A. Joshi
55 [GO] 2022―Nov―10 BRACHIAL NEURITIS FROM THE MRNA SARS-COV-2 AND INFLUENZA VACCINES J. VanLancker, D. Sheth
56 [GO] 2022―Nov―10 SARS-COV-2 ANTIBODY LEVELS CONTINUE TO RISE IN IMMUNE GLOBULIN PREPARATIONS Q. Wang, H. Park
57 [GO] 2022―Nov―10 SARS-COV-2 INFECTION ASSOCIATED WITH NEW SEVERE HYPEREOSINOPHILIA AND MULTIPLE ORGAN DAMAGE J. Eremija, N. Odisho Domit, T. Carr
58 [GO] 2022―Nov―10 RESISTANCE TO GLUCOCORTICOSTEROID THERAPY IN PATIENTS WITH SARS-COV-2 INFECTION WITH ELEVATED MARKERS OF ENDOTOXEMIA V. Beloglazov, I. Yatskov, L. DuBuske
59 [GO] 2022―Nov―01 The intersection of the sunshine act, sutton's law, and the pandemic Marcus Shaker
60 [GO] 2022―Oct―22 COVID-19 patients are characterized by dysregulated levels of membrane and soluble CD48 Hadas Pahima, Ilan Zaffran, Eli Ben-Chetrit, Amir Jarjoui, Pratibha Gaur, Maria Laura Manca, et al. (+7)
61 [GO] 2022―Oct―12 Enhanced SARS-CoV-2 IgG durability following COVID-19 mRNA booster vaccination and comparison of BNT162b2 with mRNA-1273 Samuel M. Ailsworth, Behnam Keshavarz, Nathan E. Richards, Lisa J. Workman, Deborah D. Murphy, Michael R. Nelson, et al. (+2)
62 [GO] 2022―Sep―07 Split-Dosing of COVID-19 Vaccines Provides Non-Inferior Antibody Responsiveness to Conventional Vaccine Dosing Amal Musa, Macy Wood, Andrew Rorie, Sara M. May, Joel Van De Graaff, Jill A. Poole
63 [GO] 2022―Aug―18 Antibody response to coronavirus disease 2019 vaccines after allergic reaction to first dose Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
64 [GO] 2022―Aug―13 Industry Payments to Allergists and Clinical Immunologists in the United States during the COVID-19 pandemic Anju Murayama, Sae Kamamoto, Hiroaki Saito, Tetsuya Tanimoto, Akihiko Ozaki
65 [GO] 2022―Jul―30 Anxiety in Adults with Allergic Rhinitis During the Coronavirus Disease 2019 Pandemic: A Canadian Perspective Kayley Xu, Sophia Linton, Adam Sunavsky, Sarah Garvey, Hannah Botting, Lisa M Steacy, et al. (+3)
66 [GO] 2022―Jul―23 Causation or coincidence? Phenotype of asthma exacerbations during the coronavirus disease 2019 pandemic Christian Coletta, Mitchell H. Grayson
67 [GO] 2022―Jul―23 Lessons from the IMPAACT of coronavirus disease 2019 public health restrictions on food allergy-associated anxiety Michael A. Golding, Jennifer L.P. Protudjer
68 [GO] 2022―Jul―17 Patch Testing Results in Adult Patients with Dermatitis during the COVID-19 Pandemic Stephanie Kong, Stephanie L Mawhirt
69 [GO] 2022―Jun―16 Immunizing the Imperfect Immune System: COVID-19 Vaccination in Patients with Inborn Errors of Immunity Jessica R. Durkee-Shock, Michael D. Keller
70 [GO] 2022―May―28 Predictors of seroconversion following COVID-19 vaccination Sergio E. Chiarella, Sarah M. Jenkins, Carin Y. Smith, Vikas Prasad, Fnu Shakuntulla, Vaibhav Ahluwalia, et al. (+3)
71 [GO] 2022―May―21 Allergic Reactions to the COVID-19 vaccine (ARCOV) study: the McGill University Health Center (MUHC) experience Faisal ALMuhizi, Michael Fein, Sofianne Gabrielli, Louise Gilbert, Christos Tsoukas, Moshe Ben-Shoshan, et al. (+2)
72 [GO] 2022―May―20 A case of coronavirus disease 2019 messenger RNA vaccine tolerance and immune response despite presence of anti-polyethylene glycol antibodies Kristen B. Corey, Grace Koo, Cosby A. Stone, Susan F. Kroop, William H. Fissell, Steven Kozlowski, et al. (+2)
73 [GO] 2022―May―20 The Role of the Allergist in Coronavirus Disease 2019 Vaccine Allergy Safety Valerie Chiang, Chinmoy Saha, Jackie Yim, Elaine Y.L. Au, Andy K.C. Kan, Kong Siu Harris Hui, et al. (+10)
74 [GO] 2022―May―19 Outcomes of Allergic Type Reactions Following mRNA COVID-19 Vaccination at Three Military Medical Centers Benjamin D. St Clair, Donna L. Hoffman, Bruce McClenathan, Taylor Banks, Rachel U. Lee
75 [GO] 2022―May―17 Antibody Response to Graded Dosing of COVID-19 mRNA Vaccines After Allergic Reaction to First Dose Sara W Van Meerbeke, Merritt L Fajt, Rachel V Marini, Robyn T Domsic, Andrej A Petrov
76 [GO] 2022―Apr―23 COVID-19 Related Anxiety Is Associated with Uncontrolled Asthma in Adults Kamal M Eldeirawi, Sharmilee M. Nyenhuis, Luz Huntington-Moskos, Barbara J. Polivka
77 [GO] 2022―Apr―23 Decreased food-allergy-specific anxiety and increased general anxiety in parents of children with food allergies during COVID-19 Clara Westwell-Roper, Sharon To, Lianne Soller, Edmond S. Chan, S. Evelyn Stewart
78 [GO] 2022―Apr―08 Effect of the COVID-19 pandemic on morbidity among children hospitalized for an asthma exacerbation Nada Alabdulkarim, Jiaxiang Gai, James Bost, Dinesh Pillai, Stephen J. Teach, Deepa Rastogi
79 [GO] 2022―Apr―06 Specific antibody response of 14 common variable immunodeficiency patients to three BNT162b2 mRNA COVID-19 vaccinations Nizar Abo-Helo, Emad Muhammad, Sondus Ghaben-Amara, Shai Cohen
80 [GO] 2022―Apr―05 One year later: What Have We Learned About the Allergenicity and Adverse Reactions Associated with the SARS-CoV-2 vaccines Ana M Copaescu, Jaime S Rosa Duque, Elizabeth J. Phillips
81 [GO] 2022―Mar―26 The impact of dupilumab treatment on SARS-CoV-2/COVID-19 antibody responses in atopic dermatitis patients Benjamin Ungar, Leore Lavin, Alexandra K. Golant, Alyssa Gontzes, Eden David, Yeriel D. Estrada, et al. (+3)
82 [GO] 2022―Mar―25 Asthma and COVID-19 related outcomes in hospitalized patients: A single center experience Amy Ludwig, Caryn Brehm, Christopher Fung, Shijing Jia, Jonathan P. Troost, Laura Leuenberger, et al. (+5)
83 [GO] 2022―Mar―12 COVID-19 Vaccine Administration in Patients with Reported Reactions to Polyethylene Glycol- and Polysorbate-Containing Therapeutics Iris M. Otani, Lulu R. Tsao, Monica Tang
84 [GO] 2022―Mar―04 Social Well-Being Amongst Children With vs. Without Food Allergy Before and During COVID-19 Kaitlyn A. Merrill, Elissa M. Abrams, Elinor Simons, Jennifer Lisa Penner Protudjer
85 [GO] 2022―Mar―04 Graded COVID-19 Vaccine Administration: A Safe Alternative to Vaccine Avoidance Mitchell M. Pitlick, Alexei Gonzalez-Estrada, Miguel A. Park
86 [GO] 2022―Mar―04 SARS-CoV-2 vaccines are well tolerated in patients with mastocytosis Gülseren Tuncay, Ozge Can Bostan, Ebru Damadoglu, Gül Karakaya, Ali Fuat Kalyoncu
87 [GO] 2022―Feb―25 Medication Adherence in Medicare Enrolled Older Adults with Asthma Before and During the COVID-19 Pandemic Olivia L. Ramey, Armando Silva Almodóvar, Milap C. Nahata
88 [GO] 2022―Feb―25 Effects of COVID-19 Pandemic on Children, Adolescents and Young Adults with Asthma in Rhode Island: Patterns in Emergency Department Utilization with Geospatial Mapping Daphne Koinis-Mitchell, Christina D'Angelo, Shira Dunsiger, Elizabeth McQuaid, Michelle L. Rogers
89 [GO] 2022―Feb―25 Ultra-rush immunotherapy with polymerized extracts during COVID-19 pandemic: safety of restarting administrations without dose-adjustments Mariana Bragança, José Luís Plácido, Luís Amaral
90 [GO] 2022―Feb―22 Coronavirus disease 2019 messenger RNA vaccine skin tests and serum histamine levels in allergic reactions Anita Kohli-Pamnani, Kristen Zapata, Tiffany Gibson, Pamela L. Kwittken
91 [GO] 2022―Feb―22 Immune parameters during anaphylaxis to messenger RNA coronavirus disease 2019 vaccines Luc de Chaisemartin, Antoine Diep, Cécile Gonnin, Angèle Soria, Annick Barbaud, Pascale Nicaise-Roland
92 [GO] 2022―Feb―12 A COVID-19 Vaccinated Patient with Phosphoinositide 3-Kinase Disease with Mild Illness Following SARS-CoV-2 Infection Sandeep Sarkaria, Amanpreet Kalkat, Robert Hostoffer
93 [GO] 2022―Feb―04 A Pediatric Asthma Camp Experience during the COVID-19 Pandemic Victoria Eng, Gary Paul Moreno, Jinny Chang, Myron Liebhaber
94 [GO] 2022―Jan―31 The Effect of COVID-19 on Asthma Visits Sean Stout, Helen Murphy, Aarti Pandya, Hung-Wen Yeh, Jay Portnoy
95 [GO] 2021―Dec―29 Psychological Impacts of COVID-19 on people with Asthma, Allergic Rhinitis and Food Allergy Alyssa G. Burrows, Anne K. Ellis
96 [GO] 2021―Dec―16 Impact of COVID-19 pandemic on frequency and severity of asthma exacerbations in an inner-city population Stefanie Zaner Fischell, Jonathan M. Fischell, Gloribel Olexa, Charles Callahan, Mary E. Bollinger
97 [GO] 2021―Nov―23 Messenger RNA vaccines and neutralizing anti-severe acute respiratory syndrome coronavirus 2 antibodies in patients with immunodeficiency Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
98 [GO] 2021―Nov―20 Delayed hypersensitivity to the Comirnaty COVID-19 vaccine presenting with pneumonitis and rash Dr Alex Stoyanov, Dr Graeme Thompson, Dr Monique Lee, Professor Connie Katelaris
99 [GO] 2021―Nov―16 Utility and Futility of Skin Testing to Address Concerns Surrounding mRNA COVID-19 Vaccine Reactions Mitchell M Pitlick, Andrea N Sitek, Michael E D'Netto, Kelley N Dages, Sergio E Chiarella, Alexei Gonzalez-Estrada, et al. (+2)
100 [GO] 2021―Nov―04 D020 ROLE OF CELLULAR CASPASES AND THERAPEUTIC POTENTIAL OF A PAN-CASPASE INHIBITOR, EMRICASAN, IN COVID-19. O. Alpan, R. Gupta, M. Latterich, M. Hubka, Z. Bukhari, L. Ndhlovu
101 [GO] 2021―Nov―04 M127 A MULTIFACETED APPROACH TO DIAGNOSIS AND MANAGEMENT OF POST COVID-19 ASSOCIATED DYSPNEA IN ADOLESCENTS M. Nevid, C. Lomas, N. Rabinovitch
102 [GO] 2021―Nov―04 A044 COVID-19 IN CVID: A LARGE HOSPITAL EXPERIENCE J. Greenmyer, A. Joshi
103 [GO] 2021―Nov―04 P155 ASSOCIATION OF PRIOR COVID-19 INFECTION AND SYSTEMIC SIDE EFFECTS AFTER COVID-19 VACCINATION IN HEALTHCARE POPULATION V. Phomakay, J. Lieberman
104 [GO] 2021―Nov―04 P003 DIAGNOSTIC UTILITY OF PEG/POLYSORBATE 80 SKIN TESTING AND ORAL CHALLENGE FOR COVID-19 MRNA VACCINE ALLERGY J. Ohtola, D. Lang, L. Pien
105 [GO] 2021―Nov―04 P191 DERMATITIS RELATED TO PPE UTILIZATION AMONG HEALTHCARE WORKERS DURING THE COVID-19 PANDEMIC D. Frankel, S. Mawhirt, M. Akerman, L. Fonacier
106 [GO] 2021―Nov―04 P173 IMPROVING ACCESS TO HEALTHCARE THROUGH TELEMEDICINE IN AN UNDERSERVED ASTHMA POPULATION DURING THE COVID-19 PANDEMIC A. Heffes-Doon, U. Kothari, A. Webb
107 [GO] 2021―Nov―04 P001 ALLERGISTS LEAD ANAPHYLAXIS PREPAREDNESS VIRTUAL WORKSHOPS FOR EARLY CHILDHOOD PROFESSIONALS AMIDST THE COVID-19 PANDEMIC M. Duggins, R. Shah, M. Baker, M. Marget, M. Oxford, A. Hoyt
108 [GO] 2021―Nov―04 A005 PATCH TESTING RESULTS IN ADULT PATIENTS WITH DERMATITIS DURING THE COVID-19 PANDEMIC S. Kong, S. Mawhirt, S. Islam
109 [GO] 2021―Nov―04 P091 BIOMARKERS OF INFLAMMATION AND IMMUNE REGULATION IN COVID-19 PATIENTS AND COVID 19 VACCINATED INDIVIDUALS M. Trusevich, L. Titov, T. Amvrosieva, I. Belskaya, L. DuBuske
110 [GO] 2021―Nov―04 P154 TREATING COVID-19 PNEUMONIA WITH DOXYCYCLINE DOES NOT IMPROVE MORTALITY M. Majzoub, R. Joks
111 [GO] 2021―Nov―04 M102 A CASE OF DELAYED UVULAR ANGIOEDEMA AFTER ADMINISTRATION OF THE COVID-19 VACCINE S. Kim, N. Mambetsariev, L. Grammer
112 [GO] 2021―Nov―04 M044 POLYETHYLENE GLYCOL ALLERGY TESTING AN ADOLESCENT WITH ANAPHYLAXIS TO PEG-ASPARAGINASE BEFORE ADMINISTERING PFIZER-BIONTECH COVID-19 VACCINE M. Breidenbaugh
113 [GO] 2021―Nov―04 P006 POLYETHYLENE GLYCOL ALLERGY LABEL: NOT AN ABSOLUTE CONTRAINDICATION TO RECEIVING AN MRNA COVID-19 VACCINE M. Pitlick, K. Dages, A. Joshi, M. Park
114 [GO] 2021―Nov―04 A001 MRNA COVID-19 VACCINE ADVERSE EVENTS FOLLOWING IMMUNIZATION: SHOULD YOU RECOMMEND THE SECOND DOSE? B. St. Clair, D. Hoffman, R. Lee, J. Montgomery
115 [GO] 2021―Nov―04 P177 COVID-19 VACCINE ADVERSE REACTIONS IN HOSPITAL EMPLOYEES H. Jin, M. Ackerman, M. Phillips, C. Cohan, S. Salvati, M. Wilkenfeld, L. Fonacier
116 [GO] 2021―Nov―04 M260 EVALUATION OF THE HYPERSENSITIVITY RISK OF THE COVID-19 VACCINE COMPONENTS: A SERIES OF CASE REPORTS T. Delgado Guzmán, S. Gonzalez-Diaz, R. Villarreal Gonzalez, C. De Lira-Quezada, A. Chávez Ruiz, C. Macouzet-Sanchez
117 [GO] 2021―Nov―04 M098 A CASE OF HEREDITARY A-TRYPTASEMIA EXACERBATION FOLLOWING SECOND DOSE OF MRNA COVID-19 VACCINE ON OMALIZUMAB J. Li, R. Saff
118 [GO] 2021―Nov―04 M275 COVID-19 VACCINE RELATED URTICARIAL VASCULITIS S. Bhatti, J. McCracken
119 [GO] 2021―Nov―04 M015 A PATIENT WITH AN ALLERGIC REACTION TO THE PFIZER COVID-19 VACCINE SUBSEQUENTLY TOLERATES JOHNSON&JOHNSON VACCINATION A. Patterson, Z. Ren, M. Jerath
120 [GO] 2021―Nov―04 M019 COVID-19 VACCINE-ASSOCIATED ANAPHYLAXIS: BASOPHIL ACTIVATION IN A SPECIFIC IGE AND IGG NEGATIVE PATIENT S. Jiang, E. Smith, V. Vo, V. Sampath, T. Snow, M. Shah, et al. (+3)
121 [GO] 2021―Nov―04 M004 UNUSUAL ANAPHYLACTIC REACTION TO COVID-19 VACCINE-CONSTRUCTING A HISTORY WITH TECHNOLOGY AS AN AID E. Montgomery, D. Sheth
122 [GO] 2021―Nov―04 P095 LEVELS OF IGG TO SARS-COV-2 IN RECIPIENTS OF COVID-19 VACCINES: LONGITUDINAL MONITORING WITH QUANTITATIVE ASSAY J. Patel, B. Keshavarz, N. Richards, L. Workman, L. Muehling, D. Murphy, et al. (+4)
123 [GO] 2021―Nov―04 P094 IMMUNOLOGIC EFFICACY OF POOLED MESENCHYMAL STEM CELLS IN PATIENTS WITH SEVERE COVID-19-ASSOCIATED PNEUMONIA A. Rynda, A. Hancharou, N. Antonevich, S. Aliakseichyk, Y. Pankratova, V. Isachkin, L. DuBuske
124 [GO] 2021―Nov―04 P096 LIPOPOLYSACCHARIDE-BINDING SYSTEMS IN PATIENTS WITH SARS-COV-19 INFECTION HAVING VARIOUS DEGREES OF SEVERITY V. Beloglazov, I. Yatskov, A. Nikolaeva, E. Lavrenchuk, L. DuBuske
125 [GO] 2021―Nov―04 A041 DETECTION OF SARS-COV-2 ANTIBODIES IN IMMUNOGLOBULIN PRODUCTS K. Cousins, K. Sano, G. Singh, N. Aboelregal, S. Jeong, H. Ho, et al. (+2)
126 [GO] 2021―Nov―04 A045 INADEQUATE SARS-COV-2 ANTIBODY RESPONSE TO MRNA SARS-COV-2 VACCINE IN ADOLESCENT KIDNEY TRANSPLANT RECIPIENTS L. Loop, C. Crane, C. Anterasian, B. Geng, E. Ingulli
127 [GO] 2021―Nov―04 M013 SUCCESSFUL FOUR-STEP GRADED-DOSE ADMINISTRATION TO THE PFIZER-MRNA SARS-COV-2 VACCINE IN A PATIENT WITH PREVIOUS ANAPHYLAXIS D. Morgenstern-Kaplan, I. Carrillo-Martin, C. Rivera, M. Parkulo, A. Gonzalez-Estrada
128 [GO] 2021―Nov―04 M010 DIAGNOSTIC CHALLENGE IN EVALUATING THE RISK AND MANAGEMENT OF ALLERGIC REACTION(S) TO SARS-COV-2 VACCINES E. Abou-Jaoude, T. Nsouli, N. Diliberto, S. Nsouli, J. Bellanti
129 [GO] 2021―Nov―04 M191 IMMUNE ASSESSMENT IN POST-ACUTE SEQUALA OF SARS-COV2 INFECTION (PASC): EVIDENCE OF PERSISTENT IMMUNE ACTIVATION? V. Ahluwalia, V. Iyer, A. Joshi
130 [GO] 2021―Oct―28 Atopic comorbidity has no impact on severity and course of COVID-19 disease in adult patients Julia Zarnowski, Paula Kage, Jan-Christoph Simon, Regina Treudler
131 [GO] 2021―Oct―25 The COVID-19 Pandemic: Adverse Effects on the Social Determinants of Health in Children and Families Elissa M Abrams, Matthew Greenhawt, Marcus Shaker, Andrew D Pinto, Ian Sinha, Alexander Singer
132 [GO] 2021―Oct―25 Allergic reactions to COVID-19 vaccines and addressing vaccine hesitancy: Northwell Health experience Blanka Kaplan, Sherry Farzan, Gina Coscia, David W. Rosenthal, Alissa McInerney, Artemio M. Jongco, et al. (+2)
133 [GO] 2021―Oct―25 Delayed angioedema following SARS-CoV-2 mRNA vaccine administration Melissa M. Watts, Laura E. Maurer, Leslie C. Grammer, Carol A. Saltoun, Whitney W. Stevens
134 [GO] 2021―Oct―19 Asthma in older adults with severe COVID-19: clinical outcomes and predictors of mortality. Sergey N. Avdeev, Anna A. Pozdnakova, Viliya V. Gaynitdinova, Svetlana Yu Chikina, Anna E. Vlasenko
135 [GO] 2021―Oct―13 Trends in racial disparities in asthma emergency department utilization during COVID-19 Rubayet Hossain, Fang Zhao, Marie Michenkova, David Kaelber, Yasir Tarabichi
136 [GO] 2021―Oct―13 Polyethylene glycol and polysorbate testing in twelve patients prior to or after COVID-19 vaccine administration Taya Carpenter, Justin Konig, Jillian Hochfelder, Subhadra Siegel, Melissa Gans
137 [GO] 2021―Sep―30 Evaluation of Anaphylaxis Risk by Skin Testing with Covid-19 mRNA Vaccines on Anaphylactic Patients Marek M. Pienkowski, Stefan M. Pienkowski
138 [GO] 2021―Sep―27 National decline in asthma exacerbations in US during COVID19 pandemic Regina W Lam, Jonathan W Inselman, Molly M Jeffery, Jacob T Maddux, Matthew A Rank
139 [GO] 2021―Sep―20 Non-IgE mediated allergy associated with Pfizer-BioNTech COVID-19 vaccine excipient polyethylene glycol Shirley Y. Jiang, Eric M. Smith, Victor Vo, Cezmi Akdis, Kari C. Nadeau
140 [GO] 2021―Sep―03 COVID-19 Vaccine Hypersensitivity Evaluated with Vaccine and Excipients Allergy Skin Testing Anita Kohli-Pamnani, Kristen Zapata, Tiffany Gibson, Pamela L. Kwittken
141 [GO] 2021―Aug―01 Eosinophilic inflammation, coronavirus disease 2019, and asthma Sanjay Ramakrishnan, Mona Bafadhel
142 [GO] 2021―Jul―31 Specific antibody response of common variable immunodeficiency patients to BNT162b2 COVID-19 vaccination Nizar Abo-helo, Emad Muhammad, Sondus Ghaben-amara, Josef Panasoff, Shai Cohen
143 [GO] 2021―Jul―31 Biphasic anaphylaxis after first dose of mRNA COVID-19 vaccine with positive polysorbate 80 skin testing Mitchell M Pitlick, Miguel A Park, Alexei Gonzalez-Estrada, Sergio E Chiarella
144 [GO] 2021―Jul―11 Anaphylaxis-related knowledge and concerns in Canadian families during COVID-19 Sofianne Gabrielli, Jennifer LP Protudjer, Gregory Gooding, Jennifer Gerdts, Moshe Ben-Shoshan
145 [GO] 2021―Jun―20 Telemedicine During the COVID-19 Pandemic for Pediatric Eosinophilic Esophagitis Patients Anupama Kewalramani, Jaylyn Waddell, Elaine Leonard Puppa
146 [GO] 2021―Jun―18 Eosinophils in antiviral immunity and (perhaps) a benefit of having asthma during the SARS-CoV2 pandemic Ryan Eid, Larry Borish
147 [GO] 2021―May―19 Seroconversion Following COVID-19 Vaccination in Immune Deficient Patients Jacqueline Squire, Dr. Avni Joshi
148 [GO] 2021―May―18 Skin Prick Test Practice In Allergy Clinics During Covid-19 Pandemic Resat Kendirlinan, Pamir Cerci, Dilsad Mungan
149 [GO] 2021―May―16 Home epinephrine-treated reactions in food allergy oral immunotherapy: Lessons from COVID-19 lockdown Liat Nachshon, Michael R Goldberg, Michael B Levy, Naama Epstein-Rigbi, Yael Koren, Arnon Elizur
150 [GO] 2021―May―08 Commentary on Eosinophilic inflammation, COVID-19, and asthma - are inhaled corticosteroids the missing link? Kam Sing Ho, Daniel Howell, Linda Rogers, Bharat Narasimhan, Hannah Verma, David Steiger
151 [GO] 2021―May―07 Investigating Air Pollution as a Contributor to Health Disparities During the COVID-19 Pandemic Harleen Marwah, Natalie Rosseau, Sowmya Mangipudi, Caitlin Ward, Anjeni Keswani
152 [GO] 2021―May―05 Risk of allergic reaction in patients with atopic disease and recent COVID-19 vaccination Kelley N. Dages, Mitchell M. Pitlick, Avni Y. Joshi, Miguel A. Park
153 [GO] 2021―May―01 The evidence is in that asthma is not associated with severe coronavirus disease 2019 Dylan T. Timberlake, Mitchell H. Grayson
154 [GO] 2021―Apr―08 Disproportionality Analysis of Anaphylactic Reactions after Vaccination with mRNA COVID-19 Vaccines in the United States Guillermo Rodriguez-Nava, Goar Egoryan, Daniela Patricia Trelles-Garcia, Maria Adriana Yanez-Bello, Ricardo Murguia-Fuentes
155 [GO] 2021―Mar―27 Drug Desensitization in the Covid-19 Pandemic Era: Local Success to Widespread Potential Kimberly G. Blumenthal, Mariana Castells, Aleena Banerji
156 [GO] 2021―Mar―27 Misdiagnosis of systemic allergic reactions to mRNA COVID-19 vaccines John M Kelso
157 [GO] 2021―Mar―26 Evaluating the impact of COVID-19 on asthma morbidity: a comprehensive analysis of potential influencing factors Olga L Guijon, Tricia Morphew, Morphew Consulting, Louis Ehwerhemuepha, Stanley P Galant
158 [GO] 2021―Mar―26 Polyethylene Glycol and Polysorbate Skin Testing in the Evaluation of COVID-19 Vaccine Reactions: Early Report Mitchell M Pitlick, Andrea N Sitek, Susan A Kinate, Avni Y Joshi, Miguel A Park
159 [GO] 2021―Mar―26 Prepping for a pandemic Kelsey Lecerf, Mitchell H. Grayson
160 [GO] 2021―Feb―27 The Relationship Between Asthma, Eosinophilia, and Outcomes in COVID-19 Infection Kam Sing Ho, Daniel Howell, Linda Rogers, Bharat Narasimhan, Hannah Verma, David Steiger
161 [GO] 2021―Feb―25 Asthma in COVID-19 suspected and diagnosed patients Lijuan Cao, Sandra Lee, James G. Krings, Adriana M. Rauseo, Daniel Reynolds, Rachel Presti, et al. (+4)
162 [GO] 2021―Feb―19 Asthma in patients with coronavirus disease 2019: a systematic review and meta-analysis Li Shi, Jie Xu, Wenwei Xiao, Ying Wang, Yuefei Jin, Shuaiyin Chen, et al. (+3)
163 [GO] 2021―Jan―23 Asthma and allergic diseases are not risk factors for hospitalization in children with COVID-19 Burcin Beken, Gokcen Kartal Ozturk, Fatma Deniz Aygun, Cigdem Aydogmus, Himmet Haluk Akar
164 [GO] 2021―Jan―23 Effect of Patient and Parental Anxiety on Adherence to Subcutaneous Allergen Immunotherapy During COVID-19 Pandemic Ilknur Kulhas Celik, Azize Pinar Metbulut, Ozden Sukran Uneri, Gulser Senses Dinc, Emine Dibek Misirlioglu
165 [GO] 2021―Jan―23 Insights from American College of Allergy, Asthma, and Immunology COVID-19 Vaccine Task Force: Allergic Reactions to mRNA SARS-CoV-2 Vaccines: Allergic Reactions to mRNA SARS-CoV-2 Vaccines Kevin R. Murphy, Niraj C. Patel, Daniel Ein, Mary Hudelson, Sangeetha Kodoth, Gailen D. Marshall, et al. (+2)
166 [GO] 2021―Jan―14 SARS-CoV2 infection in those on Mepolizumab therapy Adnan Azim, Laura Pini, Zeeshan Khakwani, Santosh Kumar, Peter Howarth
167 [GO] 2020―Dec―30 Monitoring Neutrophil to Lymphocyte Ratio in COVID-19 Patients Receiving Tocilizumab Nicholas L. Hartog, Alan T. Davis, Jeremy W. Prokop, Andrew Walls, Surender Rajasekaran
168 [GO] 2020―Dec―11 Zoonotic coronavirus epidemics: SARS, MERS, and COVID-19 Monica Fung, Iris Otani, Michele Pham, Jennifer Babik
169 [GO] 2020―Nov―22 Non-neutralizing antibodies and limitations of serological testing for SARS-CoV-2 in patients receiving replacement immunoglobulin products Deepti Vellaichamy Manian, Chelsee Jensen, Elitza S. Theel, John R. Mills, Avni Joshi
170 [GO] 2020―Nov―13 P350 EFFECTS OF ATOPIC DISEASE ON DISEASE SEVERITY IN COVID-19 D. Timberlake, D. Narayanan, P. Ogbogu, R. Raveendran, B. Prince, R. Scherzer, et al. (+2)
171 [GO] 2020―Nov―13 M030 RITUXIMAB-INDUCED SERUM SICKNESS IN A PEDIATRIC PATIENT WITH MULTIPLE AUTOIMMUNE DISEASES AND HISTORY OF COVID-19 K. Nguyen, A. Kazatsky
172 [GO] 2020―Nov―13 M412 A BALANCING ACT: TREATMENT OF COVID-19 AND CYTOMEGALOVIRUS IN A PATIENT WITH PRIMARY IMMUNODEFICIENCY V. Szafron, M. Pereira, T. Vogel, D. Leung, L. Forbes-Satter
173 [GO] 2020―Nov―13 A050 THE IMPACT OF COVID-19 AND DISEASE CONTROL MEASURES ON PEDIATRIC FOOD ALLERGY PARENTS/CAREGIVERS AND PATIENTS C. Warren, S. Chinthrajah, P. Newmark, L. Herbert, S. Fox, K. Nadeau, et al. (+4)
174 [GO] 2020―Nov―13 M405 COVID-19 ASSOCIATED EOSINOPHILIC LICHEN PLANUS G. Hudes, M. Weingarten, D. Sanchez Tejera
175 [GO] 2020―Nov―13 M402 FACIAL CONTACT DERMATITIS DUE TO MASKS IN THE COVID-19 ERA Y. Dhamija, N. Khan, K. Schmidlin
176 [GO] 2020―Nov―13 M413 COVID-19 IN A PATIENT WITH CVID AND CONTRAINDICATIONS TO SEVERAL POTENTIAL TREATMENTS E. Ender, P. Timothy
177 [GO] 2020―Nov―13 M403 COVID-19 IN A PATIENT WITH HYPER-EOSINOPHILIC SYNDROME TREATED WITH MEPOLIZUMAB Z. Khakwani, S. Kumar
178 [GO] 2020―Nov―13 M410 COVID-19 INFECTION IN A PATIENT WITH SECONDARY HYPOGAMMAGLOBULINEMIA D. Maghen, G. Lutz, A. Schneider
179 [GO] 2020―Nov―13 M406 SELF-LIMITED COVID-19 INFECTION IN ARTEMIS HYPOMORPHIC SCID: ARE B CELLS DISPENSABLE? S. Gabryszewski, D. Sun, S. Jyonouchi, K. Sullivan, S. Henrickson
180 [GO] 2020―Nov―13 M400 MANAGING A CASE OF REPORTED LOCAL LIDOCAINE ALLERGY IN A PREGNANT WOMAN DURING COVID-19 PANDEMIC H. Jin, O. Waqar, R. Miller
181 [GO] 2020―Nov―13 M409 ELECTRONIC CIGARETTE OR VAPING PRODUCT USE-ASSOCIATED LUNG INJURY AMIDST THE COVID-19 PANDEMIC A. Diaz, S. Sani, S. Mawhirt
182 [GO] 2020―Nov―13 P201 PERCEIVED APATHY FROM PHYSICIANS ASSOCIATED WITH EMOTIONAL DISTRESS AMID COVID-19 PANDEMIC IN ADULTS WITH ASTHMA S. Alonzi, T. Coaston, M. Silverstein
183 [GO] 2020―Nov―13 M414 LOMATIUM DISSECTUM RASH: A COMPLICATION OF COVID-19 PROPHYLAXIS THERAPY J. Nelson
184 [GO] 2020―Nov―13 M408 AN UNUSUAL MISSED DIAGNOSIS OF MULTIFACETED CLINICAL CASE OF CORONAVIRUS DISEASE 2019 MIMICKING UNCONTROLLED ASTHMA S. Nsouli
185 [GO] 2020―Nov―13 M407 COMPLICATIONS OF CORONAVIRUS IN A PATIENT WITH CVID D. Urschel, M. Cardenas-Morales, V. Hernandez-Trujillo
186 [GO] 2020―Nov―13 M411 ACTIVE TUBERCULOSIS (TB) MASQUERADING AS AN ASTHMA EXACERBATION DURING A SARS-COV-2 (COVID 19) PANDEMIC G. Hudes, M. Beronilla
187 [GO] 2020―Nov―13 M404 PERSISTENT POSITIVITY OF SARS-COV-2 NASOPHARYNGEAL PCR TEST IN A CHILD WITH ASTHMA M. Pitlick, A. Joshi
188 [GO] 2020―Nov―13 A060 INNER CITY ASTHMA TELE-MEDICINE DURING COVID PANDEMIC K. Kwong
189 [GO] 2020―Nov―06 Potential Association of Mast Cells with COVID-19 Theoharis C. Theoharides
190 [GO] 2020―Nov―05 Controlled Trials Needed to Prove Efficacy and Safety of Convalescent Plasma Therapy in COVID-19 Nicholas Hartog, Amanda Holsworth, Surender Rajasekaran
191 [GO] 2020―Oct―12 Asthma is associated with increased risk of intubation but not hospitalization or death in coronavirus disease 2019 Jamie A. Rosenthal, Seemal F. Awan, Jonathan Fintzi, Anjeni Keswani, Daniel Ein
192 [GO] 2020―Sep―18 High anxiety and health-related quality-of-life in families with children with food allergy during COVID-19 J.L.P. Protudjer, M. Golding, M.R. Salisbury, E.M. Abrams, L.E. Roos
193 [GO] 2020―Sep―07 Differentiating characteristics of asthmatic patients in the SARS-CoV2 infection. José Lemus Calderón, Pedro Beneyto Martin, Raúl Guzmán Rodriguez, Horacio Caligaris Cataldi, Carlos Senent Sánchez
194 [GO] 2020―Aug―25 U.S. Public Health Resources for COVID-19 That Are Relevant to Allergy/Immunology Joy Hsu
195 [GO] 2020―Aug―25 Children and adolescents with allergy and/or asthma seem to be protected from coronavirus disease 2019 Giorgio Ciprandi, Amelia Licari, Gaetana Filippelli, Maria Angela Tosca, Gian Luigi Marseglia
196 [GO] 2020―Aug―18 A fatal case of COVID-19 in a patient with common variable immunodeficiency Jyotsna Mullur, Alberta Wang, Anna Feldweg
197 [GO] 2020―Aug―17 Perceived stress links income loss and urticaria activity during the COVID-19 pandemic Minxue Shen, Yangjian Xiao, Yan Yuan, Xiang Chen, Jie Li
198 [GO] 2020―Aug―01 Anaphylactic shock following diagnosis of COVID-19 Alberto Alvarez-Perea, María Luisa Baeza
199 [GO] 2020―Aug―01 Clinical course and outcomes in patients with asthma hospitalized for SARS-CoV-2 pneumonia:a single-center, retrospective study. Carlo Lombardi, Elena Roca, Barbara Bigni, Marcello Cottini, Giovanni Passalacqua
200 [GO] 2020―Jul―24 Smell loss is a prognostic factor for lower severity of COVID-19 Katharine J. Foster, Emilio Jauregui, Bobby Tajudeen, Faraz Bishehsari, Mahboobeh Mahdavinia
201 [GO] 2020―Jul―22 COVID-19 - associated urticaria with angioedema in a morbidly obese male successfully treated with glucocorticoids Richard F. Lockey, Stephanie N. Hudey
202 [GO] 2020―Jul―18 Atopy is predictive of a decreased need for hospitalization for COVID-19 Anjeni Keswani, Klodian Dhana, Jamie A. Rosenthal, Donyea Moore, Mahboobeh Mahdavinia
203 [GO] 2020―Jul―01 Idiopathic Nonhistaminergic Acquired Angioedema in a Patient with COVID-19 Veronica Azmy, Jemma Benson, Keith Love, Ryan Steele
204 [GO] 2020―Jul―01 Use of inhaled corticosteroids in asthma and coronavirus disease 2019 Brian Lipworth, Rory Chan, Chris RuiWen Kuo
205 [GO] 2020―Jun―22 Patient Satisfaction with Telemedicine Encounters in an Allergy/Immunology Practice During the COVID-19 Pandemic S. Shahzad Mustafa, Luanna Yang, Mahta Mortezavi, Karthik Vadamalai, Allison Ramsey
206 [GO] 2020―Jun―14 COVID-19, SEVERE ASTHMA AND BIOLOGICS Ismael García-Moguel, Rocío Díaz Campos, Sergio Alonso Charterina, Consuelo Fernández Rodríguez, Jesús Fernández Crespo
207 [GO] 2020―Jun―10 COVID-19 and allergen immunotherapy: theoretical benefits invite to adjustments in practice recommendations Désirée Larenas-Linnemann, Noel Rodríguez-Pérez, Jose Antonio Ortega-Martell, Virginia Blandon Vijil, Jorge A. Luna-Pech
208 [GO] 2020―Jun―04 Positive Outcome in a COVID-19 patient with Common Variable Immunodeficiency after IVIG Rana Aljaberi, Kholoud Wishah
209 [GO] 2020―May―27 Rethinking Respiratory Function Test Lab in the Era of COVID-19 : considerations about the “today” and the “day after” Lombardi Carlo, Milanese Manlio, Cottini Marcello
210 [GO] 2020―May―22 Drug allergy labeling and delabeling in the coronavirus disease 2019 era Mariana C. Castells
211 [GO] 2020―May―11 Clinical course of asthma in 4 cases of COVID-19 infection Christopher D. Codispoti, Sindhura Bandi, Payal Patel, Mahboobeh Mahdavinia
212 [GO] 2020―May―06 Dietary Management of Food Protein-Induced Enterocolitis Syndrome during COVID-19 Pandemic Marion Groetch, Raquel Durban, Rosan Meyer, Carina Venter, Anna Nowak-Wegrzyn
213 [GO] 2020―May―06 Asthma, biologics, corticosteroids, and coronavirus disease 2019 Ayobami T. Akenroye, Robert Wood, Corinne Keet
214 [GO] 2020―May―05 The Clinical Observation of a CVID Patient Infected with COVID-19 Lauren Fill, Lauren Hadney, Kelsey Graven, Roberta Persaud, Robert Hostoffer
215 [GO] 2020―May―05 Managing FPIES during the COVID-19 pandemic-expert recommendations A. Nowak-Wegrzyn, A. Cianferoni, J.A. Bird, A. Fiocchi, J.C. Caubet, Stefania Arasi, et al. (+12)
 [1] 

215 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec